Changes in the etiology of valvular heart disease in the rapidly aging Korean population

Jang, Shin Yi; Ju, Eun-Young; Seo, Su Ra; Choi, Ji Yeon; Park, Sung‐Ji; Kim, Duk Kyung; Park, Seung Woo

doi:10.1016/j.ijcard.2014.04.112

Cited by 25 publications

(25 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The age-standardized prevalence of amyloidosis was calculated with the direct method [ 11 ] using the beneficiaries of health insurance from the Korean National Health Insurance Statistical Yearbook from 2006 through 2015 [ 12 – 21 ] and the estimated Korean population in 2015 [ 22 ] as a reference [ 23 , 24 ].…”

Section: Methodsmentioning

confidence: 99%

Prevalence of Amyloidosis in Korea

Seo

Jang

Lee

et al. 2017

Orphanet J Rare Dis

Self Cite

View full text Add to dashboard Cite

BackgroundThe aim of this study was to assess in amyloidosis prevalence in Korea between 2006 and 2015.MethodsPrimary diagnoses related to amyloidosis, regardless of subtype, were collected from the Korean National Health Insurance Service from 2006 through 2015.ResultsOverall, the age-standardized prevalence of amyloidosis was 0.93 (95% confidence interval (CI) 0.81, 1.04) persons per 100,000 persons in 2006 and 1.91 (95% CI 1.78, 2.05) persons per 100,000 persons in 2015. This included an increase from 0.43 (95% CI 0.35, 0.51) to 1.04 (95% CI 0.94, 1.14) persons per 100,000 persons in men and from 0.49 (95% CI 0.40, 0.57) to 0.87 (95% CI 0.77, 0.96) persons per 100,000 persons in women. In particular, the age-standardized prevalence of amyloidosis showed a greater increase in patients aged 65 years or older and in patients aged 45–64 years than in patients aged 20–44 years, for both men and women.ConclusionsThe overall age-standardized prevalence of amyloidosis was approximately 2 persons per 100,000 persons in 2015. The overall age-standardized prevalence of amyloidosis increased between 2006 and 2015, especially in individuals aged 45–64 and older than 65 years.Electronic supplementary materialThe online version of this article (10.1186/s13023-017-0705-2) contains supplementary material, which is available to authorized users.

show abstract

Section: Methodsmentioning

confidence: 99%

Prevalence of Amyloidosis in Korea

Seo

Jang

Lee

et al. 2017

Orphanet J Rare Dis

Self Cite

View full text Add to dashboard Cite

show abstract

“…Table 4). [ 14 , 15 ] In addition, we had concerns about the accuracy of the data recorded. Therefore, we checked the distribution of both CHD and acquired heart disease by heart surgery status using data from the Korean Heart Foundation from 2006 to 2015.…”

Section: Discussionmentioning

confidence: 99%

“…This score included interventions in pediatric departments (971 in 2006 and 1891 in 2015), departments of medicine (71 in 2006 and 483 in 2015), and departments of chest surgery (3504 in 2006 and 3349 in 2015). Further, to determine the accuracy of the data we used in this study, [ 15 ] we considered the classification of 298 mutually independent disease categories from the Korean National Health Insurance Service yearbook from 2006 to 2013 (Supp. Fig.…”

Section: Discussionmentioning

confidence: 99%

“…Second, the National Health Insurance benefit records might have missed adult patients with CHD who did not use medical services, paid for their own medical expenses, or had Medical Aid. [ 15 ] Third, we could not evaluate preexisting complex diseases, the perils of CHD, or corrected transposition of the great arteries because of data limitations. Fourth, we could not determine the cause of death because Korean National Health Insurance benefit data do not include that information.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and mortality of congenital heart disease in Korean adults

et al. 2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…During the past 50 years, the etiology of valvular heart diseases has changed greatly in developed countries, with an increase in non-rheumatic valvular heart diseases such as age-related calcific aortic stenosis (AS) [ 1 , 2 ] . AS is now considered one of the most common valvular diseases in the developed world.…”

Section: Introductionmentioning

confidence: 99%

Transcatheter aortic valve implantation (TAVI) with balloon-expandable valve: early experience from China

Lu¹,

Pei²,

Wu³

et al. 2015

Revista Brasileira De Cirurgia Cardiovascular

View full text Add to dashboard Cite

ObjectiveThe aim of the current study was to evaluate the early experience of the application of transcatheter aortic valve implantation with the balloon-expandable system in China. The transcatheter aortic valve implantation technology has been widely used for patients with inoperable severe aortic stenosis in the developed world. The application of transcatheter aortic valve implantation is still in the early stages of testing in China, particularly for the balloon-expandable valve procedure.MethodsThis was a retrospective study. All patients undergoing transcatheter aortic valve implantation with balloon-expandable system in our hospital between 2011 and 2014 were included. Edwards SAPIEN XT Transcatheter Heart Valve was used. The improvement of valve and heart function was evaluated as well as 30-day mortality and major complications according to the VARC-2 definition.ResultsA total of 10 transcatheter aortic valve implantation procedures with the balloon-expandable system were performed in our hospital, of which 9 were transfemoral and 1 was transapical. The median age was 76 years, and the median STS score and Logistic EuroSCORE (%) were 8.9 and 16.2. The implantation was successfully conducted in all patients, only 2 patients had mild paravalvular leak. There was no second valve implantation. Moreover, no 30-day mortality or complications was reported. Following the transcatheter aortic valve implantation procedure, the heart and valve functions had improved significantly. During the follow-up period of 3-34 months, one patient died of lung cancer 13 months after the operation.ConclusionThis early experience has provided preliminary evidence for the safety and efficacy of transcatheter aortic valve implantation procedure with the balloon-expandable system in the developing world with an increasing aging population.

show abstract

Changes in the etiology of valvular heart disease in the rapidly aging Korean population

Cited by 25 publications

References 13 publications

Prevalence of Amyloidosis in Korea

Prevalence of Amyloidosis in Korea

Prevalence and mortality of congenital heart disease in Korean adults

Transcatheter aortic valve implantation (TAVI) with balloon-expandable valve: early experience from China

Contact Info

Product

Resources

About